Avia Pharma
Avia was founded in 2016 and focuses on medically positioned products within dermatology, allergy, women’s health, urology, and general OTC products. The Company has successfully executed on its strategy to build its own brand portfolio and to grow its Northern European presence over time, through a combination of M&A (having already done 6 since inception), in-licensing of additional products and growing market share across the portfolio. Avia is today a well-diversified platform present across the Nordics and Germany with headquarters in Stockholm, Sweden, and with offices in Germany and Finland.
Avia facts
Pharmaceuticals
December 2023
Stockholm, Sweden
Jacob Calmvik (CEO)
Jonas Karlander (CFO)
Carolina Oscarius-Dahl
Gustav J. Lundgren
Olga Court-Payen
90
Investment Thesis
- Exposure to large and fundamentally attractive OTC and Rx market niches
- Existing portfolio comprising high-quality products
- Organic and semi-organic profitable growth initiatives across existing and new products
- Platform for M&A growth across Northern European countries
UN SDG Goals
Other portfolio companies
Avia Pharma
Avia is a leading North European OTC/Rx platform
Stille
Stille is a well-established pioneer in the development of premium surgical instruments and advanced surgical tables
Decon
Decon develops, assembles, and distributes high-quality, power-assisted electrical solutions for wheelchairs